SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with GXLV.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to GXLV.L
GXLV.L charges 0.15% annually. There are 3 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 0.12% | 644.55M | Sep 2017 | GXLV.L vs XSHC.L | |
| Invesco Health Care S&P US Select Sector UCITS ETF... | 0.14% | 461.66M | Dec 2009 | GXLV.L vs XLVS.L | |
| Invesco US Health Care Sector UCITS ETF | 0.14% | 343.20M | Dec 2009 | GXLV.L vs XLVP.L | |
| iShares S&P 500 Health Care Sector UCITS ETF USD (... | 0.15% | 2.55B | Jun 2020 | GXLV.L vs IUHC.L | |
| SPDR MSCI Europe Health Care UCITS ETF | 0.18% | — | Dec 2014 | GXLV.L vs HEAE.L |
Best Risk-Adjusted Alternatives to GXLV.L
GXLV.L has a PortfoliosLab risk / return rank of 38. There are 9 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 76.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 76 | 624.54M | Oct 2017 | GXLV.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 72 | 55.04M | Mar 2018 | GXLV.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | 72 | 407.93M | Nov 2014 | GXLV.L vs SBIO.L | |
| Global X Genomics & Biotechnology UCITS ETF | 62 | 20.00M | Nov 2021 | GXLV.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 61 | 12.52M | Dec 2021 | GXLV.L vs WBIO.L |
Top Performing GXLV.L Alternatives (YTD)
GXLV.L is at -1.77% YTD. There are 14 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 12.27%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| Global X Genomics & Biotechnology UCITS ETF | 12.27% | 20.00M | Nov 2021 | GXLV.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 12.52M | Dec 2021 | GXLV.L vs WBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 8.97% | 9.55M | May 2020 | GXLV.L vs FBT.L | |
| iShares Nasdaq US Biotechnology UCITS ETF | 4.86% | 624.54M | Oct 2017 | GXLV.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 4.58% | 55.04M | Mar 2018 | GXLV.L vs BTEE.L |
Lowest Volatility Alternatives to GXLV.L
GXLV.L has 18.62% 1-year volatility. There are 17 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 13.70%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| SPDR MSCI World Health Care UCITS ETF | 13.70% | — | Apr 2016 | GXLV.L vs HEAW.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | 14.52% | 913.84M | Aug 2010 | GXLV.L vs HLTW.L | |
| Xtrackers MSCI World Health Care UCITS ETF 1C | 14.57% | 3.40B | Mar 2016 | GXLV.L vs XDWH.L | |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 14.72% | 644.55M | Sep 2017 | GXLV.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 14.76% | 343.20M | Dec 2009 | GXLV.L vs XLVP.L |
Lowest Drawdown Alternatives to GXLV.L
GXLV.L has a 1-year max drawdown of -11.51%. There are 10 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | -6.89% | 624.54M | Oct 2017 | GXLV.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | -7.63% | 55.04M | Mar 2018 | GXLV.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | -7.64% | 407.93M | Nov 2014 | GXLV.L vs SBIO.L | |
| L&G Pharma Breakthrough UCITS ETF | -9.93% | 14.12M | Jan 2018 | GXLV.L vs BIGT.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | -10.12% | 913.84M | Aug 2010 | GXLV.L vs HLTW.L |
Other ETFs from State Street
The 10 most viewed State Street ETFs shown here include ACWD.L, SWRD.L, ACWI.L and span 6 categories. AUM among these funds goes as high as $42B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| SPDR MSCI All Country World UCITS ETF | Global Equities | 73 | 11.54% | 16.32B | May 2011 | GXLV.L vs ACWD.L | |
| SPDR MSCI World UCITS ETF | Large Cap Growth Equities | 69 | 9.88% | 20.32B | Feb 2019 | GXLV.L vs SWRD.L | |
| SPDR MSCI ACWI UCITS ETF | Global Equities | 86 | 11.83% | 12.13B | May 2011 | GXLV.L vs ACWI.L | |
| State Street SPDR S&P 500 UCITS ETF | S&P 500 | 75 | 10.31% | 41.79B | Aug 2025 | GXLV.L vs SPY5.L | |
| SPDR MSCI ACWI IMI | Global Equities | 75 | 12.35% | 6.47B | May 2011 | GXLV.L vs IMID.L | |
| SPDR S&P 500 UCITS ETF | S&P 500 | 83 | 10.53% | 31.06B | Mar 2012 | GXLV.L vs SPX5.L | |
| SPDR MSCI World UCITS ETF | Global Equities | 83 | 10.05% | 15.10B | Feb 2019 | GXLV.L vs SWLD.L | |
| SPDR S&P US Dividend Aristocrats UCITS ETF Dis | Large Cap Blend Equities, Dividend | 41 | 7.22% | 2.69B | Jun 2019 | GXLV.L vs USDV.L | |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | Small Cap Value Equities | 75 | 13.75% | 984.14M | Feb 2015 | GXLV.L vs USSC.L | |
| SPDR S&P 500 UCITS ETF USD Acc | S&P 500 | 74 | 10.35% | 41.79B | Aug 2025 | GXLV.L vs SPYL.L |
Often Compared With GXLV.L
Investors most often compare GXLV.L with PCGH.L, KURE.L, PPH. These 19 comparison targets span 3 categories, based on PortfoliosLab usage data.
Compare GXLV.L with Any Fund or Stock
Compare GXLV.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair GXLV.L with funds that move differently
SPDR S&P US Health Care Select Sector UCITS ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to GXLV.L.
Explore GXLV.L Diversifiers